ReviewInternational journal of molecular sciences2020

Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection.

Sanna Iivanainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.